Skip to main content

Advertisement

SpringerLink
Log in

Modified Gastric Cancer AJCC Staging with a Classification Based on the Ratio of Regional Lymph Node Involvement: A Population-Based Cohort Study

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Purpose

This study evaluated the additional value of lymph node ratio (LNR) when used in combination with the 8th American Joint Committee on Cancer (AJCC) staging system for gastric cancer (GC) to establish a new LNR-based AJCC (rAJCC) staging system.

Methods

We searched the Surveillance, Epidemiology, and End Results database to identify patients who had undergone surgery to resect nonmetastatic GC during the period from 2004 to 2013. Recursive partitioning analysis was used to identify the optimal cutoff points for LNR, and an LNR-based N classification system was designed accordingly. The two staging systems were compared in terms of discriminatory ability, as measured by the concordance index. The likelihood ratio Chi square test was used to assess prognostic homogeneity.

Results

A total of 13,027 patients were included in the final analysis. All of the included patients, who belonged to the 8th AJCC IIIA category, could be further classified into the rIIB, rIIIA, rIIIB, and rIIIC subgroups using the proposed rAJCC classification system. A difference in 5-year overall survival rate was found between patients classified as having rIIA disease and those classified as having rIIIC disease (66.7% vs. 5.1%). The rAJCC staging system was superior to the 8th AJCC staging system in terms of discriminatory capacity and prognostic homogeneity.

Conclusions

A new rAJCC staging system is proposed, with prognostic superiority to the 8th AJCC staging system for patients with GC. The rAJCC staging system may serve as a useful tool in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.

    Google Scholar 

  2. Jiang L, Yao Z, Zhang Y, et al. Comparison of lymph node number and prognosis in gastric cancer patients with perigastric lymph nodes retrieved by surgeons and pathologists. Chin J Cancer Res. 2016;28(5):511–8.

    PubMed  PubMed Central  Google Scholar 

  3. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

    PubMed  Google Scholar 

  4. Degiuli M, Sasako M, Ponti A, et al. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg. 2014;101(2):23–31.

    CAS  PubMed  Google Scholar 

  5. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374(9688):477–90.

    PubMed  PubMed Central  Google Scholar 

  6. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439–49.

    PubMed  Google Scholar 

  7. Wu CW, Hsiung CA, Lo SS, et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol. 2006;7(4):309–15.

    CAS  PubMed  Google Scholar 

  8. Cho KH, Lee HJ, Lee WH. Reliability of rehabilitative ultrasound imaging for the medial gastrocnemius muscle in poststroke patients. Clin Physiol Functional Imaging. 2014;34(1):26–31.

    Google Scholar 

  9. Liu P, Wang Y, Hu H, Mao Y, Huang D, Li L. Change of muscle architecture following body weight support treadmill training for persons after subacute stroke: evidence from ultrasonography. BioMed Res Int. 2014;2014:11.

    Google Scholar 

  10. Deutsch GB, O’Connor V, Sim MS, Lee JH, Bilchik AJ. Incorporating surgical quality into the AJCC 7th edition improves staging accuracy in gastric cancer. Ann Surg Oncol. 2015;22(1):11-6.

    PubMed  Google Scholar 

  11. Morgan JW, Ji L, Friedman G, Senthil M, Dyke C, Lum SS. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery. JAMA Surg. 2015;150(1):37–43.

    PubMed  Google Scholar 

  12. Shen JY, Kim S, Cheong JH, et al. The impact of total retrieved lymph nodes on staging and survival of patients with pT3 gastric cancer. Cancer. 2007;110(4):745–51.

    PubMed  Google Scholar 

  13. Jun KH, Lee JS, Kim JH, Kim JJ, Chin HM, Park SM. The rationality of N3 classification in the 7th edition of the International Union Against Cancer TNM staging system for gastric adenocarcinomas: a case-control study. Int J Surg. 2014;12(9):893–6.

    PubMed  Google Scholar 

  14. Li FX, Zhang RP, Liang H, Quan JC, Liu H, Zhang H. Validity and necessity of sub-classification of N3 in the 7th UICC TNM stage of gastric cancer. Asian Pac J Cancer Prev. 2013;14(3):2091–5.

    PubMed  Google Scholar 

  15. Okholm C, Svendsen LB, Achiam MP. Status and prognosis of lymph node metastasis in patients with cardia cancer: a systematic review. Surg Oncol. 2014;23(3):140–6.

    PubMed  Google Scholar 

  16. Yeh CN, Wang SY, Hsu JT, et al. N3 subclassification incorporated into the final pathologic staging of gastric cancer: a modified system based on current AJCC staging. Medicine (Balt). 2015;94(8):e575.

    Google Scholar 

  17. Hanna GB, Amygdalos I, Ni M, et al. Improving the standard of lymph node retrieval after gastric cancer surgery. Histopathology. 2013;63(3):316–24.

    PubMed  Google Scholar 

  18. Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23(28):7114–24.

    PubMed  Google Scholar 

  19. Lu J, Wang W, Zheng CH, et al. Influence of total lymph node count on staging and survival after gastrectomy for gastric cancer: an analysis from a two-institution database in China. Ann Surg Oncol. 2017;24(2):486–93.

    PubMed  Google Scholar 

  20. Okusa T, Nakane Y, Boku T, et al. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet. 1990;170(6):488–94.

    CAS  PubMed  Google Scholar 

  21. Attaallah W, Gunal O, Manukyan M, Ozden G, Yegen C. Prognostic impact of the metastatic lymph node ratio on survival in rectal cancer. Ann Coloproctol. 2013;29(3):100–5.

    PubMed  PubMed Central  Google Scholar 

  22. Elshaer M, Gravante G, Kosmin M, Riaz A, Al-Bahrani A. A systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma. Ann R Coll Surg Engl. 2017;99(2):101–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Feng JF, Huang Y, Chen L, Zhao Q. Prognostic analysis of esophageal cancer in elderly patients: metastatic lymph node ratio versus 2010 AJCC classification by lymph nodes. World J Surg Oncol. 2013;11:162.

    PubMed  PubMed Central  Google Scholar 

  24. Liu D, Chen Y, Deng M, et al. Lymph node ratio and breast cancer prognosis: a meta-analysis. Breast Cancer. 2014;21(1):1–9.

    PubMed  Google Scholar 

  25. Zhang BY, Yuan J, Cui ZS, Li ZW, Li XH, Lu YY. Evaluation of the prognostic value of the metastatic lymph node ratio for gastric cancer. Am J Surg. 2014;207(4):555–65.

    PubMed  Google Scholar 

  26. De Ridder M, Vinh-Hung V, Van Nieuwenhove Y, Hoorens A, Sermeus A, Storme G. Prognostic value of the lymph node ratio in node positive colon cancer. Gut. 2006;55(11):1681.

    PubMed  PubMed Central  Google Scholar 

  27. Yamashita K, Hosoda K, Ema A, Watanabe M. Lymph node ratio as a novel and simple prognostic factor in advanced gastric cancer. Eur J Surg Oncol. 2016;42(9):1253–60.

    CAS  PubMed  Google Scholar 

  28. Xu DZ, Geng QR, Long ZJ, et al. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol. 2009;16(2):319–26.

    PubMed  Google Scholar 

  29. Lee YC, Yang PJ, Zhong Y, Clancy TE, Lin MT, Wang J. Lymph node ratio-based staging system outperforms the seventh AJCC system for gastric cancer: validation analysis with National Taiwan University Hospital Cancer Registry. Am J Clin Oncol. 2017;40(1):35–41.

    PubMed  Google Scholar 

  30. Wang J, Dang P, Raut CP, et al. Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg. 2012;255(3):478–85.

    PubMed  Google Scholar 

  31. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.

    PubMed  Google Scholar 

  32. Therneau TM, Atkinson EJ. An Introduction to Recursive Partitioning Using the RPART Routine Technical Report 61. Rochester Mayo Foundation. 1997.

  33. O’Sullivan B, Huang SH, Su J, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016;17(4):440–51.

    PubMed  Google Scholar 

  34. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361–87.

    PubMed  Google Scholar 

  35. Yuan SQ, Chen YT, Huang ZP. Equipping the 8th Edition American Joint Committee on Cancer Staging for Gastric Cancer with the 15-Node Minimum: a population-based study using recursive partitioning analysis. J Gastrointest Surg. 2017;21(10):1591-8.

    PubMed  PubMed Central  Google Scholar 

  36. Lu J, Zheng ZF, Xie JW, et al. Is the 8th edition of the AJCC TNM staging system sufficiently reasonable for all patients with noncardia gastric cancer? A 12,549-patient international database study Ann Surg Oncol. 2018;25(7):2002–11.

    PubMed  Google Scholar 

  37. Zhang M, Wang J, Shi W, et al. Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy. Chin Med J (Engl). 2014;127(10):1874–8.

    PubMed  Google Scholar 

  38. Lin D, Li Y, et al. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection regardless of the examined number of lymph nodes. Am J Clin Oncol. 2013;36(4):325-30.

    PubMed  Google Scholar 

  39. Marchet A, Mocellin S, Ambrosi A, et al. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol. 2008;34(2):159–65.

    CAS  PubMed  Google Scholar 

  40. Saito H, Fukumoto Y, Osaki T, et al. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol. 2008;97(2):132–5.

    PubMed  Google Scholar 

  41. Han DS, Suh YS, Kong SH, et al. Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. J Clin Oncol. 2012;30(31):3834–40.

    PubMed  Google Scholar 

  42. Hirabayashi S, Kosugi S, Isobe Y, et al. Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer. Ann Oncol. 2014;25(6):1179–84.

    CAS  PubMed  Google Scholar 

  43. Wang ZX, Li GX, Zhou ZW, Huang ZP, Wang F, Xu RH. Validation of a nomogram for selecting patients for chemotherapy after D2 gastrectomy for cancer. Br J Surg. 2017;104(9):1226–34.

    CAS  PubMed  Google Scholar 

  44. Yuan SQ, Wu WJ, Qiu MZ, et al. Development and validation of a nomogram to predict the benefit of adjuvant radiotherapy for patients with resected gastric cancer. J Cancer. 2017;8(17):3498–505.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgment

This work was supported by Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital (CY2018-M S14).

Author information

Author notes

  1. Zeping Huang and Yutong Chen have contributed equally to this work.

Authors and Affiliations

  1. Department of General Surgery, Lan Zhou University Second Hospital, Lanzhou, China

    Zeping Huang MM, Haipeng Liu MD & Youcheng Zhang MD

  2. Department of Medical Oncology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    Yutong Chen MD

  3. Department of Nephrology, Lan Zhou University Second Hospital, Lanzhou, China

    Wenjun Zhang MD

  4. Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China

    Zixian Wang MD

Authors
  1. Zeping Huang MM
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yutong Chen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wenjun Zhang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Haipeng Liu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zixian Wang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Youcheng Zhang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Youcheng Zhang MD.

Ethics declarations

Disclosures

There is no conflict of interest regarding the publication of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, Z., Chen, Y., Zhang, W. et al. Modified Gastric Cancer AJCC Staging with a Classification Based on the Ratio of Regional Lymph Node Involvement: A Population-Based Cohort Study. Ann Surg Oncol 27, 1480–1487 (2020). https://doi.org/10.1245/s10434-019-08098-w

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-019-08098-w

Search

Navigation